Evidence map›Paper›PMID 38475464›Full record

ArticlePlants (Basel, Switzerland)2024

Therapeutic Application of

Chi-Feng Cheng, Sheue-Er Wang, Chen-Wen Lu, Thi Kim Ngan Nguyen, Szu-Chuan Shen, Chia-Ying Lien, Wu-Chang Chuang, Ming-Chung Lee, Chung-Hsin Wu

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Plants (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Chi-Feng ChengSchool of Life Science, National Taiwan Normal University, Taipei 116, Taiwan.
Sheue-Er WangDepartment of Pathological Inspection, Saint Paul's Hospital, Taoyuan 330, Taiwan.
Chen-Wen LuSchool of Life Science, National Taiwan Normal University, Taipei 116, Taiwan.
Thi Kim Ngan NguyenSchool of Life Science, National Taiwan Normal University, Taipei 116, Taiwan.
Szu-Chuan ShenSchool of Life Science, National Taiwan Normal University, Taipei 116, Taiwan.
Chia-Ying LienMaster Program of Sport Facility Management and Health Promotion, National Taiwan University, Taipei 116, Taiwan.
Wu-Chang ChuangSun Ten Pharmaceutical Co., Ltd., New Taipei City 231, Taiwan.
Ming-Chung LeeBrion Research Institute of Taiwan, New Taipei City 231, Taiwan.
Chung-Hsin WuSchool of Life Science, National Taiwan Normal University, Taipei 116, Taiwan.ORCID 0000-0002-4470-2448
National Taiwan Normal University · TWNational Taiwan University · TW

Funding

National Science and Technology Council NSTC 111-2320- B-003-003 -TTY BIOPHARM CO., LTD. and SHIUN CHAO BIOPHARM CO., LTD. N/A
6 · The paper itself

Abstract

Retinopathy caused by ultraviolet radiation and cancer chemotherapy has increased dramatically in humans due to rapid environmental and social changes. Therefore, it is very important to develop therapeutic strategies to effectively alleviate retinopathy. In China, people often choose dendrobium to improve their eyesight. In this study, we explored how

Indexed as

apoptosisARPE-19 cellschemotherapyDendrobium fimbriatuminflammationmiceoxidative stressretinopathyUV

Identifiers

PMID38475464
PMCPMC10935344
OpenAlexW4392095823

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.